16 February 2020 - The past month and a half has been hard on the Lindsay family, as Mark Lindsay has watched his daughter's condition steadily decline.

“Her lung function dropped to the point where she had to be ventilated, and they took her to ICU,” says Lindsay of his 23-year-old daughter, Chantelle. “They had to hook her up to an ECMO machine, which takes blood out of one main artery, runs it through a machine, takes the carbon dioxide out, puts the oxygen into the blood and back into her body to keep her going.”

Lindsay’s daughter has cystic fibrosis, which caused her lung function to begin declining in October. Her family wanted to prescribe her a breakthrough drug called Trikafta. However, the company hasn't applied to have it approved for use in Canada yet.

Read CTV News article